{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:14:41Z","timestamp":1790626481196,"version":"4.1.0"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Immune dysregulation, polyendocrinopathy, and enteropathy, X-linked (IPEX) syndrome is a rare disorder that has become a model of monogenic autoimmunity. IPEX is caused by mutations in <jats:italic>FOXP3<\/jats:italic> gene, a master regulator of regulatory T cells (Treg). Cases reported in the last 20 years demonstrate that IPEX clinical spectrum encompasses more than the classical triad of early-onset intractable diarrhea, type 1 diabetes (T1D) and eczema. Atypical cases of IPEX include patients with late-onset of symptoms, single-organ involvement, mild disease phenotypes or rare clinical features (e.g., atrophic gastritis, interstitial lung disease, nephropathy etc.). Several atypical presentations have recently been reported, suggesting that IPEX incidence might be underestimated. Immunosuppression (IS) treatment strategies can control the disease, however at the moment allogeneic hematopoietic stem cell transplantation (HSCT) is the only available definitive cure, therefore it is important to achieve a prompt diagnosis. This review aims to describe unusual clinical phenotypes, beyond classical IPEX. Overall, our analysis contributes to increase awareness and finally improve diagnosis and treatment intervention in IPEX in order to ensure a good quality of life.<\/jats:p>","DOI":"10.3389\/fped.2021.643094","type":"journal-article","created":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T16:53:02Z","timestamp":1612543982000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":51,"title":["Atypical Presentations of IPEX: Expect the Unexpected"],"prefix":"10.3389","volume":"9","author":[{"given":"Filippo","family":"Consonni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ciullini Mannurita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Gambineri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S0022-3476(82)80573-8","article-title":"An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy","volume":"100","author":"Powell","year":"1982","journal-title":"J Pediatr"},{"key":"B2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1172\/JCI11679","article-title":"JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome","volume":"106","author":"Chatila","year":"2000","journal-title":"J Clin Invest"},{"key":"B3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/83713","article-title":"The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3","volume":"27","author":"Bennett","year":"2001","journal-title":"Nat Genet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/nyas.13011","article-title":"From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation","volume":"1417","author":"Bacchetta","year":"2016","journal-title":"Ann NY Acad Sci"},{"key":"B5","doi-asserted-by":"publisher","first-page":"eaaz0571","DOI":"10.1126\/sciadv.aaz0571","article-title":"CRISPR-based gene editing enables FOXP3 gene repair in IPEX patient cells","volume":"6","author":"Goodwin","year":"2020","journal-title":"Sci Adv"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.jaci.2017.10.041","article-title":"Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study","volume":"141","author":"Barzaghi","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"82747","DOI":"10.1016\/j.jaip.2020.04.070","article-title":"Clinical, immunological, and genetic features in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) and IPEX-like syndrome","author":"Jamee","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2012.00211","article-title":"Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: a paradigm of immunodeficiency with autoimmunity","volume":"3","author":"Barzaghi","year":"2012","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.jaci.2008.09.027","article-title":"Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: Inconsistent correlation between forkhead box protein 3 expression and disease severity","volume":"122","author":"Gambineri","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fped.2017.00267","article-title":"Atypical late-onset immune dysregulation, polyendocrinopathy, enteropathy, X-Linked syndrome with intractable diarrhea: a case report","volume":"5","author":"Ge","year":"2017","journal-title":"Front Pediatr"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12887-018-1169-9","article-title":"A case of metaplastic atrophic gastritis in immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome","volume":"18","author":"Luo","year":"2018","journal-title":"BMC Pediatr"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13052-014-0068-4","article-title":"Late-onset of immunodysregulation, polyendocrinopathy, enteropathy, x-linked syndrome (IPEX) with intractable diarrhea","volume":"40","author":"Zama","year":"2014","journal-title":"Ital J Pediatr"},{"key":"B13","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.cgh.2005.12.014","article-title":"Mechanistic associations of a mild phenotype of immunodysregulation, polyendocrinopathy, enteropathy, X-linked syndrome","volume":"4","author":"De Benedetti","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s12026-007-0022-2","article-title":"IPEX, FOXP3 and regulatory T-cells: a model for autoimmunity","volume":"38","author":"Ochs","year":"2007","journal-title":"Immunol Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1177\/1093526619834809","article-title":"Recurrent non immune fetal hydrops associated with IPEX syndrome","volume":"22","author":"Shanes","year":"2019","journal-title":"Pediatr Dev Pathol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"599283","DOI":"10.3389\/fped.2020.599283","article-title":"Intrauterine IPEX","volume":"8","author":"Carneiro-Sampaio","year":"2020","journal-title":"Front Pediatr"},{"key":"B17","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41424-018-0064-x","article-title":"Clinical heterogeneity of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: a French multicenter retrospective study","volume":"9","author":"Duclaux-Loras","year":"2018","journal-title":"Clin Transl Gastroenterol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.clim.2018.10.005","article-title":"Hypogammaglobulinemia with decreased class-switched B-cells and dysregulated T-follicular-helper cells in IPEX syndrome","volume":"197","author":"Shamriz","year":"2018","journal-title":"Clin Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/modpathol.2008.161","article-title":"Digestive histopathological presentation of IPEX syndrome","volume":"22","author":"Patey-Mariaud De Serre","year":"2009","journal-title":"Mod Pathol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"564926","DOI":"10.1155\/2014\/564926","article-title":"Clinical case of immune dysregulation, polyendocrinopaty, enteropathy, X-linked (IPEX) syndrome with severe immune deficiency and late onset of endocrinopathy and enteropathy","volume":"2014","author":"Savova","year":"2014","journal-title":"Case Rep Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s10875-008-9196-1","article-title":"Use of sirolimus in IPEX and IPEX-like children","volume":"28","author":"Yong","year":"2008","journal-title":"J Clin Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.jpeds.2005.04.017","article-title":"Successful use of the new immune-suppressor sirolimus in IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome)","volume":"147","author":"Bindl","year":"2005","journal-title":"J Pediatr"},{"key":"B23","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.gendis.2019.10.003","article-title":"Genetics on early onset inflammatory bowel disease: an update","volume":"7","author":"Nameirakpam","year":"2020","journal-title":"Genes Dis"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.3389\/fimmu.2018.02411","article-title":"Clinical, immunological, and molecular heterogeneity of patients with the phenotype of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome","volume":"9","author":"Gambineri","year":"2018","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/pedi.12612","article-title":"FOXP3 mutations causing early-onset insulin-requiring diabetes but without other features of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome","volume":"19","author":"Hwang","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"B26","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.clim.2007.08.004","article-title":"Developmental changes of FOXP3-expressing CD4+CD25+ regulatory T cells and their impairment in patients with FOXP3 gene mutations","volume":"125","author":"Fuchizawa","year":"2007","journal-title":"Clin Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1007\/s00431-011-1588-1","article-title":"A novel mutation and unusual clinical features in a patient with immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome","volume":"170","author":"Bae","year":"2011","journal-title":"Eur J Pediatr"},{"key":"B28","doi-asserted-by":"publisher","first-page":"580","DOI":"10.24953\/turkjped.2019.04.015","article-title":"Unusual and early onset IPEX syndrome: a case report","volume":"61","author":"Dogruel","year":"2019","journal-title":"Turk J Pediatr"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00467-015-3102-x","article-title":"Renal involvement in the immunodysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) disorder","volume":"30","author":"Sheikine","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/j.1365-2133.2008.08835.x","article-title":"Cutaneous manifestations of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome","volume":"160","author":"Halabi-Tawil","year":"2009","journal-title":"Br J Dermatol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/pde.12126","article-title":"Diagnostic value of the skin lesions in immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome","volume":"30","author":"Mart\u00edn-Santiago","year":"2013","journal-title":"Pediatr Dermatol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1001\/archderm.140.4.466","article-title":"Dermatologic and immunologic findings in the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome","volume":"140","author":"Nieves","year":"2004","journal-title":"Arch Dermatol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/j.jaci.2010.09.001","article-title":"Point mutants of forkhead box P3 that cause immune dysregulation, polyendocrinopathy, enteropathy, X-linked have diverse abilities to reprogram T cells into regulatory T cells","volume":"126","author":"McMurchy","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/MPG.0b013e3181a159de","article-title":"Severe gastritis in an insulin-dependent child with an IPEX syndrome","volume":"49","author":"Scaillon","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1007\/s00467-007-0532-0","article-title":"Immunodysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome: an unusual cause of proteinuria in infancy","volume":"22","author":"Moudgil","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1007\/s00467-017-3682-8","article-title":"PLA2R-positive (primary) membranous nephropathy in a child with IPEX syndrome","volume":"32","author":"Chuva","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1111\/ped.12570","article-title":"Familial IPEX syndrome: different glomerulopathy in two siblings","volume":"57","author":"Park","year":"2015","journal-title":"Pediatr Int"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00467-009-1119-8","article-title":"Minimal change nephrotic syndrome associated with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome","volume":"24","author":"Hashimura","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s10875-014-0059-7","article-title":"Clinical heterogeneity of immunodysregulation, polyendocrinopathy, enteropathy, X-linked: pulmonary involvement as a non-classical disease manifestation","volume":"34","author":"Baris","year":"2014","journal-title":"J Clin Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fped.2016.00003","article-title":"Editorial: current challenges in immune and other acquired cytopenias of childhood","volume":"4","author":"Ghosh","year":"2016","journal-title":"Front Pediatr"},{"key":"B41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1182\/blood-2018-11-887141","article-title":"Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genes","volume":"134","author":"Hadjadj","year":"2019","journal-title":"Blood"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MOP.0000000000000551","article-title":"Signal transducer and activator of transcription gain-of-function primary immunodeficiency\/immunodysregulation disorders","volume":"29","author":"Consonni","year":"2017","journal-title":"Curr Opin Pediatr"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/j.jaci.2018.02.055","article-title":"Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects","volume":"142","author":"Schwab","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jaut.2010.06.017","article-title":"The spectrum of autoantibodies in IPEX syndrome is broad and includes anti-mitochondrial autoantibodies","volume":"35","author":"Tsuda","year":"2010","journal-title":"J Autoimmun"},{"key":"B45","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1136\/jmg.39.8.537","article-title":"Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome","volume":"39","author":"Wildin","year":"2002","journal-title":"J Med Genet"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1053\/j.gastro.2007.02.044","article-title":"Severe food allergy as a variant of IPEX syndrome caused by a deletion in a noncoding region of the FOXP3 gene","volume":"132","author":"Torgerson","year":"2007","journal-title":"Gastroenterology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.clim.2011.06.006","article-title":"Identification of FOXP3-negative regulatory T-like (CD4 +CD25 +CD127 low) cells in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome","volume":"141","author":"Otsubo","year":"2011","journal-title":"Clin Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1172\/JCI25112","article-title":"Defective regulatory and effector T cell functions in patients with FOXP3 mutations","volume":"116","author":"Bacchetta","year":"2006","journal-title":"J Clin Invest"},{"key":"B49","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s10875-015-0218-5","article-title":"Immune dysregulation syndromes (IPEX, CD27 deficiency, and others): always doomed from the start?","volume":"36","author":"Seidel","year":"2016","journal-title":"J Clin Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2337\/dc08-1188","article-title":"Clinical heterogeneity in patients with FOXP3 mutations presenting with permanent neonatal diabetes","volume":"32","author":"Rubio-Cabezas","year":"2009","journal-title":"Diabetes Care"},{"key":"B51","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/MPG.0000000000000302","article-title":"Exome sequencing identifies a novel FOXP3 mutation in a 2-generation family with inflammatory bowel disease","volume":"58","author":"Okou","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B52","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.jmii.2015.10.015","article-title":"Quantitative analysis of tissue inflammation and responses to treatment in immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome, and review of literature","volume":"49","author":"Chen","year":"2016","journal-title":"J Microbiol Immunol Infect"},{"key":"B53","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s12026-009-8112-y","article-title":"FOXP3 expression following bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning","volume":"44","author":"Dorsey","year":"2009","journal-title":"Immunol Res"},{"key":"B54","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1053\/j.gastro.2010.06.006","article-title":"Reduced expression of FOXP3 and regulatory T-cell function in severe forms of early-onset autoimmune enteropathy","volume":"139","author":"Moes","year":"2010","journal-title":"Gastroenterology"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.jaci.2010.05.021","article-title":"Stable hematopoietic cell engraftment after low-intensity nonmyeloablative conditioning in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome","volume":"126","author":"Burroughs","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/j.1365-3083.2011.02574.x","article-title":"Clinical and molecular characteristics of immunodysregulation, polyendocrinopathy, enteropathy, X-linked syndrome in China","volume":"74","author":"An","year":"2011","journal-title":"Scand J Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/nature08750","article-title":"Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate","volume":"463","author":"Zheng","year":"2010","journal-title":"Nature"},{"key":"B58","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1136\/jmg.38.12.874","article-title":"Novel mutations of FOXP3 in two Japanese patients with immune dysregulation, polyendocrinopathy, enteropathy, X linked syndrome (IPEX)","volume":"38","author":"Kobayashi","year":"2001","journal-title":"J Med Genet"},{"key":"B59","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ymgme.2014.09.007","article-title":"Phenotypic heterogeneity in monogenic diabetes: the clinical and diagnostic utility of a gene panel-based next-generation sequencing approach","volume":"113","author":"Alkorta-Aranburu","year":"2014","journal-title":"Mol Genet Metab"},{"key":"B60","doi-asserted-by":"publisher","first-page":"530","DOI":"10.3389\/fimmu.2018.00530","article-title":"Alternative splicing of FOXP3-virtue and vice","volume":"9","author":"Mailer","year":"2018","journal-title":"Front Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"eaai9297","DOI":"10.1126\/sciimmunol.aai9297","article-title":"Suppression by human FOXP3(+) regulatory T cells requires FOXP3-TIP60 interactions","volume":"2","author":"Bin Dhuban","year":"2017","journal-title":"Sci Immunol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.immuni.2018.12.001","article-title":"The biology of T regulatory type 1 cells and their therapeutic application in immune-mediated diseases","volume":"49","author":"Roncarolo","year":"2018","journal-title":"Immunity"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.643094\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T16:53:04Z","timestamp":1612543984000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.643094\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,5]]},"references-count":62,"alternative-id":["10.3389\/fped.2021.643094"],"URL":"https:\/\/doi.org\/10.3389\/fped.2021.643094","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,5]]},"article-number":"643094"}}